[go: up one dir, main page]

CONVERSE et al., 1987 - Google Patents

Plasma lipids in retinitis pigmentosa

CONVERSE et al., 1987

View PDF
Document ID
2008006559268584437
Author
CONVERSE C
McLACHLAN T
BOW A
ALVAREZ E
HUQ L
PACKARD C
SHEPHERD J
Publication year
Publication venue
Biochemical Society Transactions

External Links

Snippet

Retinitis pigmentosa (RP) is a family of hereditary retinal degenerations characterized by tunnel vision and night blindness: rod photoreceptors appear to be particularly affected in these diseases. RP is classified primarily by pattern of inheritance (Jay, 1982). We have …
Continue reading at www.researchgate.net (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders

Similar Documents

Publication Publication Date Title
Van Hoof et al. Interpretation and clinical significance of alkaline phosphatase isoenzyme patterns
US7217535B2 (en) Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy
Lim et al. Characterization of the Shank family of synaptic proteins: multiple genes, alternative splicing, and differential expression in brain and development
Noponen et al. Elevated PLA2 activity in schizophrenics and other psychiatric patients
Baggio et al. Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients.
La Belle et al. Differences in carbohydrate content of low density lipoproteins associated with low density lipoprotein subclass patterns
Fagan et al. Differences in the Aβ40/Aβ42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype
Korsching et al. Nerve growth factor in sympathetic ganglia and corresponding target organs of the rat: correlation with density of sympathetic innervation.
Mars et al. Familial hypo-β-lipoproteinemia: A genetic disorder of lipid metabolism with nervous system involvement
Koeppen et al. Defective biosynthesis of proteolipid protein in Pelizaeus‐Merzbacher disease
Yamamura et al. A new isoform of apolipoprotein E—apo E-5—associated with hyperlipidemia and atherosclerosis
Francis et al. Somatostatin content and release measured in cerebral biopsies from demented patients
Etingin et al. Calcium channel blockers enhance cholesteryl ester hydrolysis and decrease total cholesterol accumulation in human aortic tissue.
Jakoi et al. Regular structures in unit membranes. II. Morphological and biochemical characterization of two water-soluble membrane proteins isolated from the suckling rat ileum.
Benna et al. P40phox associates with the neutrophil Triton X-100-insoluble cytoskeletal fraction and PMA-activated membrane skeleton: a comparative study with P67phox and P47phox
EP0396594A1 (en) Probes for and methods of diagnosis for muscular dystrophy
Doria-Medina et al. Immunolocalization of GLUT-1 glucose transporter in rat skeletal muscle and in normal and hypoxic cardiac tissue
Alpers et al. The effects of fat feeding on apolipoprotein AI secretion from rat small intestinal epithelium
CONVERSE et al. Plasma lipids in retinitis pigmentosa
US6596500B1 (en) Binding of retinoids to M6P/IGF-II receptor
US20050047998A1 (en) Phosphoprotein target for insulin and its antagonists
WO2000021550A2 (en) Methods and compositions for treating neurodegenerative diseases
Calingasan et al. Heterogeneous expression of transketolase in rat brain
Yang et al. Extravasation of plasma proteins can confound interpretation of proteomic studies of brain: a lesson from apo AI in mesial temporal lobe epilepsy
Urade et al. Lipocalin-type prostaglandin D synthase as an enzymic lipocalin